首页 | 本学科首页   官方微博 | 高级检索  
     

2007-2010四年间鲍曼不动杆菌耐药性变迁及对亚胺培南耐药的机制研究
引用本文:陈利达,黄彬,周晓玲,陈树林. 2007-2010四年间鲍曼不动杆菌耐药性变迁及对亚胺培南耐药的机制研究[J]. 中国微生态学杂志, 2011, 23(12): 1110-1114
作者姓名:陈利达  黄彬  周晓玲  陈树林
作者单位:1. 中山大学2009级临床检验诊断学,广东广州,510080
2. 中山大学附属第一医院检验医学部,广东广州,510080
3. 东莞市人民医院检验科,广东东莞,523018
4. 中山大学2010级临床检验诊断学,广东广州,510080
摘    要:目的研究2007-2010四年间中山大学附属第一医院临床分离的鲍曼不动杆菌的耐药性迁移情况和耐亚胺培南的鲍曼不动杆菌(IRAB)的耐药机制,为临床抗感染治疗提供依据。方法采用VITEK 2型全自动微生物检测系统对细菌进行鉴定及药敏分析;用PCR方法检测碳青霉烯酶基因blaOXA-51、blaOXA-23、blaOXA-24和blaOXA-58。结果 2007-2010四年间分离鲍曼不动杆菌811株,耐药率逐年上升,其对头孢哌酮/舒巴坦、美罗培南、头孢吡肟、亚胺培南和哌拉西林/他唑巴坦的耐药率上升明显,如对亚胺培南的耐药率自2007-2010年分别为13.1%、26.0%、44.3%和59.5%。811株鲍曼不动杆菌中IRAB有311株,IRAB对抗生素的耐药率明显升高,但四年间的耐药率变化并不明显。对IRAB敏感的抗生素以阿米卡星为首,其次为头孢哌酮/舒巴坦,但头孢哌酮/舒巴坦的敏感率逐年下降。从311株IRAB中随机抽取140株,检出blaOXA-51基因阳性125株(89.3%),blaOXA-23基因阳性29株(20.7%),blaOXA-24基因阳性3株(2.14%),blaOXA-58基因阳性22株(15.7%)。结论鲍曼不动杆菌的耐药性逐年升高,以阿米卡星与头孢哌酮/舒巴坦联合应用为有效的治疗方法,产碳青霉烯酶是IRAB的主要耐药机制。

关 键 词:鲍曼不动杆菌  亚胺培南  耐药性

4 years migration of Acinetobacter baumannii and mechanisms of resistance to Imipenem from 2007 to 2010
CHEN Li-da , HUANG Bin , ZHOU Xiao-ling , CHEN Shu-lin. 4 years migration of Acinetobacter baumannii and mechanisms of resistance to Imipenem from 2007 to 2010[J]. Chinese Journal of Microecology, 2011, 23(12): 1110-1114
Authors:CHEN Li-da    HUANG Bin    ZHOU Xiao-ling    CHEN Shu-lin
Affiliation:CHEN Li-da1,HUANG Bin2,ZHOU Xiao-ling3,CHEN Shu-lin4(1.Grade 2009,Graduate School of Sun Yat-sen University,Guangzhou 510080,China,2.Department of Laboratory Medicine,the First Affiliated Hospital of Sun Yat-sen University,3.Department of Laboratory Medicine,People's Hospital of Dongguan,Dongguan 5230184,4.Grade 2010,China)
Abstract:Objective To study the migration of Acinetobacter baumannii resistance in our hospital from 2007 to 2010 and to explore the mechanism of drug resistance to imipenem.Method The Strain identification and antibiotic susceptibility of bacteria was analyzed by VITEK 2 automatic analyzer.Resistant genes such as blaOXA-51,blaOXA-23,blaOXA-24 and blaOXA-58 were determined by PCR.Result The resistance of 811 clinical Acinetobacter baumannii isolates to antibiotics,such as cefoperazone/sulbactam,imipenem,meropenem,ce...
Keywords:Acinetobacter baumannii  Imipenem  Resistance  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号